|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0009566,
umls-concept:C0038257,
umls-concept:C0040223,
umls-concept:C0155626,
umls-concept:C0162577,
umls-concept:C0205087,
umls-concept:C0288672,
umls-concept:C0441994,
umls-concept:C0581603,
umls-concept:C0699733,
umls-concept:C0936012,
umls-concept:C1261322,
umls-concept:C1274040,
umls-concept:C1511545,
umls-concept:C2587213
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-7-23
|
|
pubmed:abstractText |
Our objective was to evaluate the impact of door-to-balloon time (DBT) on mortality depending on clinical risk and time to presentation.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1558-3597
|
|
pubmed:author |
pubmed-author:BrodieBruce RBR,
pubmed-author:CoxDavidD,
pubmed-author:DudekDariuszD,
pubmed-author:GershBernard JBJ,
pubmed-author:GrinesCindy LCL,
pubmed-author:GuagliumiGiulioG,
pubmed-author:LanskyAlexandra JAJ,
pubmed-author:MehranRoxanaR,
pubmed-author:PariseHelenH,
pubmed-author:PerugaJan ZJZ,
pubmed-author:PrasadAbhiramA,
pubmed-author:StoneGregg WGW,
pubmed-author:StuckeyThomasT,
pubmed-author:WitzenbichlerBernhardB
|
|
pubmed:copyrightInfo |
Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
27
|
|
pubmed:volume |
56
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
407-13
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:20650362-Aged,
pubmed-meshheading:20650362-Angioplasty,
pubmed-meshheading:20650362-Angioplasty, Balloon, Coronary,
pubmed-meshheading:20650362-Antibodies, Monoclonal,
pubmed-meshheading:20650362-Anticoagulants,
pubmed-meshheading:20650362-Cardiology,
pubmed-meshheading:20650362-Female,
pubmed-meshheading:20650362-Heart-Assist Devices,
pubmed-meshheading:20650362-Hospitalization,
pubmed-meshheading:20650362-Humans,
pubmed-meshheading:20650362-Immunoglobulin Fab Fragments,
pubmed-meshheading:20650362-Male,
pubmed-meshheading:20650362-Middle Aged,
pubmed-meshheading:20650362-Myocardial Infarction,
pubmed-meshheading:20650362-Myocardial Revascularization,
pubmed-meshheading:20650362-Stents,
pubmed-meshheading:20650362-Time Factors,
pubmed-meshheading:20650362-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials.
|
|
pubmed:affiliation |
LeBauer Cardiovascular Research Foundation, Greensboro, North Carolina, USA.bbrodie@triad.rr.com
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
